Advanced age raises mortality risk in metastatic prostate cancer. Learn how PSA, tumour grade, and treatment influence ...
A recent study published in the Indian Journal of Surgery in March 2026 introduces a groundbreaking risk-stratification ...
Oncologic Drugs Advisory Committee (ODAC) has recognized a favorable benefit risk profile for AstraZeneca's TRUQAP® (capivasertib) in combination with abiraterone and androgen deprivation therapy (ADT ...
A dermatologist says there are safer alternatives to biotin for treating hair loss related to cancer. Hair loss is one of the ...
MELBOURNE, Australia and INDIANAPOLIS, April 30, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, ...
About one third of cancers detected by PSA screening at age 70, and more than half at age 80, are unlikely to become clinically meaningful within 15 years.
Men diagnosed at screening aged 50 years projected to have 16% chance that cancer would not have been detected within 15 ...
I’m a 75-year-old woman who’s in very good health. Since my early 50s, I’ve had issues with my cholesterol. My doctor has put ...
Evidence shows that research designed with communities — through shared governance, fair compensation, and mutual ...
Learn more THOUSAND OAKS, Calif., April 30, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2026. "Our first quarter results demonstrate the ...
This review explains how glucose scarcity, lipid disruption, amino acid deprivation, and toxic metabolites weaken CAR-T cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results